Die Sang

4PUBLICATIONS
7CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Molecular targets
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (4)

|Mar 30, 2026
Effectiveness, safety, and biomarker analysis of sacituzumab govitecan in Chinese metastatic breast cancer: a multicenter real-world study.

Mu Li, Die Sang, Jin-Feng Zhang

|Mar 04, 2025
Efficacy and safety of trastuzumab deruxtecan in Chinese patients with HER2-positive and HER2-low advanced breast cancer: a multicenter, observational, real-world study.

Die Sang, Yanfang Su, Yurong Zhang

|Jan 29, 2025
Advanced anaplastic thyroid carcinoma with positive expression of PD-L1 response to immune checkpoint inhibitors: A case report.

Shanmin Fan, Yang Yuan, Yanfang Su

|Dec 19, 2024
Real-world comparison of palbociclib, abemaciclib, and dalpiciclib as first-line treatments for Chinese HR+/HER2-metastatic breast cancer patients: a multicenter study (YOUNGBC-28).

Yifan Chen, Yizhao Xie, Die Sang

Pageof 1

Frequent Collaborators

2 joint publications

Yifan Chen

2 joint publications

Biyun Wang

1 joint publications

Shanmin Fan

1 joint publications

Yang Yuan